BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Liu H, Zhou Z, Zhao L, Fei Y, Chen H, Zhang F, Zhang X. Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review. Clin Rev Allergy Immunol 2021;60:17-30. [PMID: 33159635 DOI: 10.1007/s12016-020-08817-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 He H, Luo M, Xiong J. Efficacy of bortezomib in reduction of systemic lupus erythematosus disease activity index score: A meta-analysis. Eur J Inflamm 2022;20:1721727X2211051. [DOI: 10.1177/1721727x221105152] [Reference Citation Analysis]
2 Brezovec N, Perdan-Pirkmajer K, Čučnik S, Sodin-Šemrl S, Varga J, Lakota K. Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases. Int J Mol Sci 2021;22:4095. [PMID: 33920997 DOI: 10.3390/ijms22084095] [Reference Citation Analysis]
3 Shen C, Xue X, Zhang X, Wu L, Duan X, Su C. Dexamethasone reduces autoantibody levels in MRL/lpr mice by inhibiting Tfh cell responses. J Cell Mol Med 2021;25:8329-37. [PMID: 34318604 DOI: 10.1111/jcmm.16785] [Reference Citation Analysis]
4 Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol 2022;13:833424. [PMID: 35222423 DOI: 10.3389/fimmu.2022.833424] [Reference Citation Analysis]